Ivan A. Savin

Ivan A. Savin

Auto-generated profile, based on publicly available information

Ivan A. Savin

Department of Clinical Epidemiology, National Medical Research Center of Neurosurgery Named after Academician N.N. Burdenko, 125047 Moscow, Russia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2018 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
KEKsenia Ershova
Ksenia Ershova
ISIvan Savin
Ivan Savin
NKNataliya Kurdyumova
Nataliya Kurdyumova
DWDarren Wong
Darren Wong
GDGleb Danilov
Gleb Danilov
OEOlga Ershova
Olga Ershova
Background: The impact of infection prevention and control (IPC) programs in limited resource countries such as Russia are largely unknown due to a lack of reliable data. The aim of this study is to evaluate the effect of an IPC program with respect to healthcare associated infection (HAI) prevention and to define the incidence of HAIs in a Russian ICU. Methods: A pioneering IPC program was implemented in a neuro-ICU at Burdenko Neurosurgery Institute in 2010 and included hand hygiene, surveillance, contact precautions, patient isolation, and environmental cleaning measures. This prospective observational cohort study lasted from 2011 to 2016, included high-risk ICU patients, and evaluated the dynamics of incidence, etiological spectrum, and resistance profile of four types of HAIs, including subgroup analysis of device-associated infections. Survival analysis compared patients with and without HAIs. Results: We included 2038 high-risk patients. By 2016, HAI cumulative incidence decreased significantly for respiratory HAIs (36.1% vs. 24.5%, p-value = 0.0003), urinary-tract HAIs (29.1% vs. 21.3%, p-value = 0.0006), and healthcare-associated ventriculitis and meningitis (HAVM) (16% vs. 7.8%, p-value = 0.004). The incidence rate of EVD-related HAVM dropped from 22.2 to 13.5 cases per 1000 EVD-days. The proportion of invasive isolates of Klebsiella pneumoniae and Acinetobacter baumannii resistant to carbapenems decreased 1.7 and 2 fold, respectively. HAVM significantly impaired survival and independently increasing the probability of death by 1.43. Conclusions: The implementation of an evidence-based IPC program in a middle-income country (Russia) was highly effective in HAI prevention with meaningful reductions in antibiotic resistance.

11 February 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
KEKuzina Ekaterina
Kuzina Ekaterina
AKAngelina Kislichkina
Angelina Kislichkina
ASAngelika Sizova
Angelika Sizova
YSYuriy Skryabin
Yuriy Skryabin
TNTatiana S. Novikova
Tatiana S. Novikova
NFNadezhda Konstantinovna Fursova
Nadezhda Konstantinovna Fursova
Background: Klebsiella pneumoniae, a member of the ESKAPE group of bacterial pathogens, has developed multi-antimicrobial resistance (AMR), including resistance to carbapenems, which has increased alarmingly due to the acquisition of carbapenemase genes located on specific plasmids. Methods: Four clinical K. pneumoniae isolates were collected from four patients of a neuro-intensive care unit in Moscow, Russia, during the point prevalence survey. The AMR phenotype was estimated using the Vitec-2 instrument, and whole genome sequencing (WGS) was done using Illumina and Nanopore technologies. Results: All strains were resistant to beta-lactams, nitrofurans, fluoroquinolones, sulfonamides, aminoglycosides, and tetracyclines. WGS analysis revealed that all strains were closely related to K. pneumoniae ST39, capsular type K-23, with 99.99% chromosome identity. The novelty of the study is the description of the strains carrying simultaneously three large plasmids of the IncHI1B, IncC, and IncFIB groups carrying the carbapenemase genes of three types, blaOXA-48, blaNDM-1, and blaKPC-2, respectively. The first of them, highly identical in all strains, was a hybrid plasmid that combined two regions of the resistance genes (blaOXA-48 and blaTEM-1 + blaCTX-M-15 + blaOXA-1 + catB + qnrS1 + int1) and a region of the virulence genes (iucABCD, iutA, terC, and rmpA2::IS110). Conclusion: The spread of K. pneumoniae strains carrying multiple plasmids conferring resistance even to last-resort antibiotics is of great clinical concern.

6 August 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
NFNadezhda Konstantinovna Fursova
Nadezhda Konstantinovna Fursova
Mikhail V. FursovMikhail V. Fursov
Mikhail V. Fursov
EAEvgeny I. Astashkin
Evgeny I. Astashkin
AFAnastasiia D. Fursova
Anastasiia D. Fursova
TNTatiana S. Novikova
Tatiana S. Novikova
OEOlga N. Ershova
Olga N. Ershova
Acinetobacter baumannii is one of the significant healthcare-associated meningitis agents characterized by multidrug resistance and a high mortality risk. Thirty-seven A. baumannii strains were isolated from thirty-seven patients of Moscow neuro-ICU with meningitis in 2013–2020. The death rate was 37.8%. Strain susceptibility to antimicrobials was determined on the Vitek-2 instrument. Whole-genome sequencing was conducted using Illumina technology; the sequence types (ST), capsular types (KL), lipooligosaccharide outer core locus (OCL), antimicrobial resistance genes, and virulence genes were identified. The prevalent ST was ST2, belonging to the international clone IC2, and rarer, ST1, ST19, ST45, ST78, ST106, and ST400, with prevalence of KL9 and OCL1. Twenty-nine strains belonged to multidrug-resistant (MDR) and eight extensively drug-resistant (XDR) categories. Genes conferring resistance to beta-lactams (blaPER, blaGES, blaADC, blaCARB, blaCTX-M, blaTEM, and blaOXA-types), aminoglycosides (aac, aad, ant, aph, and arm), tetracyclines (tet), macrolides (msr and mph), phenicols (cml, cat, and flo), sulfonamides (dfr and sul), rifampin (arr), and antiseptics (qac) were identified. Virulence genes of nine groups (Adherence, Biofilm formation, Enzymes, Immune evasion, Iron uptake, Regulation, Serum resistance, Stress adaptation, and Antiphagocytosis) were detected. The study highlights the heterogeneity in genetic clones, antimicrobial resistance, and virulence genes variability among the agents of A. baumannii meningitis, with the prevalence of the dominant international clone IC2.

2 November 2020 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
ABA. I. Baranich
A. I. Baranich
ASA. A. Sychev
A. A. Sychev
NZN. E. Zakharova
N. E. Zakharova
ISI. A. Savin
I. A. Savin
AOA. V. Oshorov
A. V. Oshorov
APA. A. Potapov
A. A. Potapov
Коагулопатия, ассоциированная с черепно-мозговой травмой (ЧМТ), признана одним из факторов риска неблагоприятного исхода у пациентов с ЧМТ. Цель исследования: уточнение показаний к переливанию свежезамороженной плазмы (СЗП) в остром периоде ЧМТ. Материалы и методы: в ретроспективно-проспективное обсервационное исследование включено 160 пациентов 18‒59 лет c изолированной ЧМТ в первые 48 ч после травмы. Пациенты оценены по шкале комы Глазго (ШКГ), выделены две исследуемые группы: первая ШКГ ≤ 8 баллов, вторая – ШКГ ≥ 9 баллов. Всем пациентам проведены анализы стандартной коагулограммы (активированное частичное тромбопластиновое время, протромбиновый индекс, концентрация фибриногена). У 42 – дополнительно выполнялась тромбоэластометрия. Оценены особенности трансфузии СЗП и исходы травмы. Результаты: согласно стандартной коагулограмме, гипокоагуляция выявлена у 50,6% пациентов, согласно тромбоэластометрии – в 22,7% случаев. Чаще СЗП использовали при тяжелой ЧМТ (83%) при снижении протромбинового индекса. Заключение: у пациентов в остром периоде изолированной ЧМТ предпочтительна минимизация использования СЗП, изолированное снижение ПТИ не должно являться триггером к трансфузии СЗП.